Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Doxycycline compared to prednisolone therapy for patients with bullous pemphigoid : cost-effectiveness analysis of the BLISTER trial

Tools
- Tools
+ Tools

The UK Dermatology Clinical Trials Network BLISTER Study Group (Including: Mason, James, Chalmers, J. R., Godec, T., Nunn, A. J., Kirtschig, G., Wojnarowska, F., Childs, M., Whitham, D., Schmidt, E., Harman, K, Walton, S., Chapman, A. and Williams, H. C.). (2018) Doxycycline compared to prednisolone therapy for patients with bullous pemphigoid : cost-effectiveness analysis of the BLISTER trial. British Journal of Dermatology, 178 (2). pp. 415-423. doi:10.1111/bjd.16006 ISSN 0007-0963.

[img]
Preview
PDF
WRAP-Doxycycline-prednisolone-forpatients-bullous-pemphigoid-Mason-2018.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution Non-commercial No Derivatives 4.0.

Download (751Kb) | Preview
[img] PDF
WRAP-doxycycline-compared-prednisolone-therapy-patients-bullous-pemphigoid-Mason-2017.pdf - Accepted Version
Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer.

Download (1129Kb)
Official URL: https://doi.org/10.1111/bjd.16006

Request Changes to record.

Abstract

Background:
Bullous pemphigoid (BP) is an autoimmune blistering skin disorder associated with significant morbidity and mortality. Doxycycline and prednisolone to treat bullous pemphigoid were compared within a randomised controlled trial (RCT).

Objectives:
To compare the cost-effectiveness of doxycycline-initiated and prednisolone-initiated treatment for patients with BP.

Methods:
a multicentre, parallel-group, investigator-blinded RCT. Within-trial analysis used bivariate regression of costs and QALYs, with multiple imputation of missing data, informing a probabilistic assessment of incremental treatment cost-effectiveness from a health service perspective

Results:
In the base case, there was no robust difference in costs or QALYs per patient at 1 year comparing doxycycline-initiated therapy with prednisolone-initiated therapy (net cost: £959, 95% CI –£24 to £1941; net QALYs: –0.024, 95% CI –0.088 to 0.041). However, findings varied by baseline blister severity. For patients with mild or moderate blistering (≤30) net costs and outcomes were similar. For patients with severe blistering (>30) net costs were higher (£2558, 95% CI –£82 to £5198) and quality of life poorer (–0.090 QALYs, 95% CI–0.222 to 0.042) for patients starting on doxycycline. The probability that doxycycline would be cost-effective for those with severe pemphigoid was 1.5% at a willingness to pay of £20,000/QALY.

Conclusions:
Consistent with the clinical findings of the BLISTER trial, patients with mild or moderate blistering should receive treatment guided by the safety and effectiveness of the drugs and patient preference - neither strategy is clearly a preferred use of NHS resources. However, prednisolone-initiated treatment may be more cost-effective for patients with severe blistering.

Item Type: Journal Article
Subjects: R Medicine > RL Dermatology
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences > Population, Evidence & Technologies (PET)
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
SWORD Depositor: Library Publications Router
Library of Congress Subject Headings (LCSH): Blisters -- Treatment -- Cost effectiveness, Autoimmune diseases -- Treatment -- Cost effectiveness
Journal or Publication Title: British Journal of Dermatology
Publisher: Wiley-Blackwell Publishing Ltd.
ISSN: 0007-0963
Official Date: February 2018
Dates:
DateEvent
February 2018Published
22 September 2017Available
22 September 2017Accepted
Volume: 178
Number: 2
Page Range: pp. 415-423
DOI: 10.1111/bjd.16006
Status: Peer Reviewed
Publication Status: Published
Reuse Statement (publisher, data, author rights): ** From Crossref via Jisc Publications Router.
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 22 November 2017
Date of first compliant Open Access: 8 March 2018
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
UNSPECIFIEDHealth Technology Assessment programmehttp://dx.doi.org/10.13039/501100000664

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us